Sun Pharma rallies 8% in 2 days on heavy volumes; stock nears 52-week high

Sun Pharma announced that its subsidiary Taro Pharmaceuticals USA Inc has completed the acquisition of subsidiary companies of Galderma

Shares of Sun Pharmaceutical were up 3.5 per cent at Rs 885.80 on the BSE in Wednesday's intra-day trade, surging 8 per cent in the past two trading days, amid heavy volumes. The stock of the drug maker was close to its 52-week high level of Rs 902.50 touched on February 4, 2022.

At 10:18 am, Sun Pharma was 3 per cent higher at Rs 880.50 on the BSE. In comparison, the S&P BSE Sensex was up 1 per cent at 53,958 points. A combined 3.2 million equity shares had changed hands on the counter in the first hour